Changing the Treatment Direction for Opiate Addiction: Dr. Dole's Research

References

• Ball, J. C., & Ross, A. (1991). The effectiveness of methadone treatment. New York: Springer-Verlag.
   Google Scholar
• Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: Public Views about addiction and mental illness. Psychiatric Services, 65(10), 1269–1272.
   Google Scholar
• Brecher, E. M., & the Editors of Consumer Union Reports. (1972). Licit and Illicit Drugs: The Consumer Union Report. Boston: Little Brown and Company.
   Google Scholar
• Caplehorn, J. R. M., & Bell, J. (1991). Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia, 154, 195–199.
   Google Scholar
• Courtwright, D., Joseph, H., Des Jarlais, D. (1989). Addicts who survived: An oral history of narcotics use in America (pp. 1923–1965). Nashville, TN: University of Tennessee Press.
   Google Scholar
• Dole, V. P. (1965). In the course of medical practice. New York State Journal of Medicine, 65, 927–931.
   Google Scholar
• Dole, V. P. (1970). Biochemistry of addiction. Annual Review of Biochemistry, 39, 821–840
   Google Scholar
• Dole, V. P., & Joseph, H. (1978). Long term outcome of patients treated with methadone-maintenance. Annals of the New York Academy of Sciences, 311, 181–189.
   Google Scholar
• Dole, V. P., & Kreek M. J. (1973). Methadone plasma level: Sustained by a reservoir of drug in tissue. Proceedings National Academy of Science, USA, 70, 10.
   Google Scholar
• Dole, V. P., Nyswander, M. (1965). A medical treatment for diacetylmorphine (heroin) addiction. JAMA, 193(8), 646–650.
   Google Scholar
• Dole, V. P., & Nyswander, M. E. (1967). Heroin addiction: A metabolic disease. Archives of Internal Medicine, 120, 19–24.
   Google Scholar
• Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic Blockade. Archives of Internal Medicine, 118, 304–309.
   Google Scholar
• Frank, B. (2000). An overview of heroin trends in New York City: past, present and future. Mount Sinai Journal of Medicine, 67(5&6), 340–346.
   Google Scholar
• Gearing, F. R., & Schweitzer, M. D. (1974). An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. American Journal of Epidemiology, 100, 101–112.
   Google Scholar
• Gordis, E. (1991). From science to social policy: An uncertain road. Journal of Studies on Alcoholism, 62(2), 101–109.
   Google Scholar
• Gordon, N. B., & Appel, P. (1995). Functional potential of the methadone maintained patient. Alcohol, Drugs and Driving, 11(1), 31–37.
   Google Scholar
• Gordon, N. B., & Lipset, J. (1976). Intellectual and functional status after almost ten years of methadone maintenance treatment. Presented at the American Psychological Association Convention, Washington, D.C.
   Google Scholar
• Halpern, M., & Rho, Y. M. (1966). Deaths from narcotism in NYC: Incidence, circumstances, and post mortem findings. New York State Journal of Medicine, 66(12), 2391–2408.
   Google Scholar
• Hartel, D., Selwyn, P. A., Schoenbaum, E. E. et al. (1988). Methadone maintenance treatment and reduced risk of AIDS and AID-specific mortality in intravenous drug users. Presented at the IV International Conference on AIDS. No. 8546, June 8–14; Stockholm, Sweden.
   Google Scholar
• Ho, A, & Dole V. P. (1979). Pain perception drug free and in methadone-maintained human ex-addicts. Proceedings of the Society for Experimental Biology and Medicine, 162, 392–395.
   Google Scholar
• Institute of Medicine. (1995). Rettig, R. A., & Yarmolinsky, A. (Eds.), Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press.
   Google Scholar
• Joseph, H. (1995). Medical methadone maintenance: The further concealment of a stigmatized condition (Dissertation). City University of New York, p 69.
   Google Scholar
• Joseph, H. (1970). Personal communication.
   Google Scholar
• Joseph, H. (1973). A probation department treats heroin addicts. Federal Probation, (March), 35–39.
   Google Scholar
• Joseph, H., & Appel, P. (1985). Alcoholism and methadone treatment: Consequences for the patients and the program. American Journal of Alcoholism and Drug Abuse, 11(1–2), 37–53.
   Google Scholar
• Joseph, H., & Dole, V. (1970). Methadone patients on probation and parole. Federal Probation, (June), 42–48.
   Google Scholar
• Joseph, H., Stancliff S., & Langrod, J. (2000). Methadone maintenance treatment: A review of historical and clinical issues. Mount Sinai Journal of Medicine, 67(5&6), 345–346
   Google Scholar
• King, R. B. (1953). The narcotics bureau and the Harrison Act: Jailing the healers and the sick. Yale Law Journal, 62, 784–767.
   Google Scholar
• Kipnis, S. S, Herron, A., Perez, J., & Joseph, H. (2001). Integrating the methadone patient in the traditional addiction inpatient rehabilitation program: Problems and solutions. Mount Sinai Journal of Medicine, 68(1), 28–32.
   Google Scholar
• Kreek, M. J. (2007). Opioids, dopamine, stress, and the addictions. Dialogues in Clinical Neuroscience, 9(4), 363–378.
   Google Scholar
• Kreek, M. J. (2000). History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences, 909, 186–216.
   Google Scholar
• Kreek, M. J. (1978). Medical complications in methadone patients. Annals of the New York Academy of Sciences, 311, 110–134.
   Google Scholar
• Kreek, M. J. (1973). Medical safety and side effects of methadone in tolerant individuals. JAMA, 223(6), 665–668.
   Google Scholar
• Kreek, M. J. (1973). Plasma and urine levels of methadone. New Yok State Journal of Medicine, 73(23), 2773–2777.
   Google Scholar
• Lasker Awards. (1988). V.P. Dole Clinical Medical Research. Available at: www.laskerfoundation.org/awards
   Google Scholar
• Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine, 68(1), 62–74.
   Google Scholar
• Magura S., Nwakeze P. C., Kang S. Y., & Demsky S. (1999). Program quality effects on patient outcomes during methadone maintenance: a study of 17 clinics. Substance Use and Misuse, 34(9), 1299–1324.
   Google Scholar
• Magura S., Kang S. Y., Nwakeze P. C., & Demsky S. (1998). Temporal patterns of heroin and cocaine use among methadone patients. Substance Use and Misuse, (12), 2441–2467.
   Google Scholar
• Magura S., Nwakeze P. C., & Demsky S. Y. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51–60.
   Google Scholar
• Magura S., Rosenblum A., & Rodriguez E. M. (1998). Changes in HIV risk behaviors among cocaine-using methadone patients. Journal Addictive Diseases, 17(4), 71–90.
   Google Scholar
• Martin, W. R., Wilker, A., Eades, G. C., & Pescor, F. T. (1963). Tolerance and physical dependence on morphine in rats. Psychopharmacology, 4, 247–260.
   Google Scholar
• Musto, D. F. (1999). The American Disease: Origins of Narcotic Control (3rd edition, pp. 237–238). Oxford University Press.
   Google Scholar
• National Institutes of Health. (1997). Effective medical treatment of opiate addiction. NIH Consensus Statement, 15(6), 1–38
   Google Scholar
• Payte, J. T., & Khuri, E. T. (1993). Principles of methadone dose determination. State Methadone Treatment Guidelines. Center for Substance Abuse Treatment, Treatment Improvement Protocol (TIP) Series 1. DHHS Publication No. (SMA) 93–1991. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Prentice, A. C. (1921). The problem of the narcotic drug addict. JAMA, 76, 1551–1554
   Google Scholar
• Pugliese, A. (1974). A study of the ability of methadone maintenance patients with the Wonderlic Personal test. Journal of Drug Education, 4, 323–326.
   Google Scholar
• Rothenberg, S. et al. (1977). Performance differences between addicts and non-addicts. Psychopharmacology, 52, 299–306.
   Google Scholar
• Scimeca, M. M., Seddon, S. R., Portenoy, R., & Lowinson J. (2000). Treatment of pain in methadone maintained patients. Mount Sinai Journal of Medicine, 67(5&6), 412–422.
   Google Scholar
• Toombs, A. D., & Kral, L. A. (2005). Methadone treatment for pain states. American Family Physician, 71(7), 1353–1358
   Google Scholar
• Watters, J. A., Price, R. H. (1985). The relationship of treatment policy to client retention. Appel, P. (Ed), Treatment Issue Report #56. New York: New York State Division of Substance Abuse Services. Unpublished internal report.
   Google Scholar
• Winnick, C. (2008). Personal communication.
   Google Scholar
• Yankowitz, R., Randell, J. (1977). Work adjustment of the methadone maintained corporate employee. Rehabilitation Counseling Bulletin, 20, 191–197.
   Google Scholar